March 17, 2026

Value-based Healthcare: The Vision

Founding members of the Santa Fe Project discuss the role of pathology in improving population-level health

The Pathologist

March 17, 2026

Women and Liver Fibrosis Risk: New Insights

Study reveals sex-specific differences in fibrosis associations

The Pathologist

March 16, 2026

Prostate Screening Rivals Mammography

Risk-adapted PSA and MRI strategy shows comparable population screening performance in large European trial

The Pathologist

March 16, 2026

Beyond Morphology and IHC

Can molecular profiling and AI help uncover tumor origin and actionable biomarkers?

The Pathologist

March 12, 2026

The 60 Percent Diagnostic Gap in M/E

What earlier mNGS testing could mean for labs and clinicians

The Pathologist

March 10, 2026

AI-Selected Trial Candidates are More Diverse

Could artificial intelligence-enabled medical chart review improve the speed, accuracy, and equity of study enrollment?

The Pathologist

March 09, 2026

Diabetes Risk Assessment: A New Approach

Blood-based epigenetic markers show strong prognostic potential for Type 2 diabetes

The Pathologist

February 27, 2026

Cervical Cancer Is Preventable – So Why Do We Miss It?

A gynecologic oncologist explores new diagnostic priorities

The Pathologist

February 26, 2026

The Test That Could Save Patients' Bladders

Blood and urine tumor DNA monitoring may identify patients who can safely avoid cystectomy

The Pathologist

February 24, 2026

The Most Sensitive Cancer Blood Test Yet

A CRISPR-powered light sensor detected trace amounts of cancer biomarkers in the blood

The Pathologist